The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy.
By M. Cooperberg, D. Pasta, E. Elkin, M. Litwin, D. Latini, Janeen Du Chane, P. Carroll. Journal of Urology, 2005
755 citations recorded by the source corpus.
Subfields: Pulmonary and Respiratory Medicine, Urology
View Paper: https://www.semanticscholar.org/paper/558c4303fe614279f801562426054ad64bc41394
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- E. Klein
- C. Magi-Galluzzi
- P. Carroll
- M. Cooperberg
- J. Simko
- S. Falzarano
- T. Maddala
- J. Chan
Citations in the corpus
- A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. (2014, methodology): “Pretreatment risk-assessment tools [8,9] based on PSA, clinical stage, Gleason score, and other biopsy characteristics fare well in identifying patients at risk of aggressive disease but predict indolent disease for only a limited proportion of patients [10,11].”